Literature DB >> 3665204

Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese.

Y Kusumoto1, S Takebayashi, T Taguchi, T Harada, S Naito.   

Abstract

For a comparative study of IgA nephropathy occurring in Japanese adolescents and adults, the clinical and histological findings and prognosis (follow-up period; 12 +/- 6 years for children and 10 +/- 5 years for adults) were compared. The subjects studied included 98 children and 86 adults. Development into renal failure occurred in 9 children (9.2%) and in 20 adults (23.3%), (p less than 0.01). The actuarial renal survival rate at year 10 after the onset of glomerulonephritis in children and adults was 95% and 80%, respectively, and at year 20, 82% and 50%, respectively. The prognosis was definitely better in the children and this was attributable to the observation that (1) the glomerular injury at the initial biopsy in children was less extensive than in adults; (2) the frequency of complication with hypertension was lower in children (27.6%) than in adults (41.9%), (p less than 0.05); (3) hypertension was one prognostic indice, even in children, after age 30; (4) after age 40, aging and arteriosclerosis were more contributory than hypertension to the progress of IgA nephropathy; and (5) the quantity of intraglomerular immune deposits and the period of deposition were not related of prognostic indices. Thus, in the long-term prognosis of IgA nephropathy in both children and adults, immunological disorders seem to have little influence while factors such as hypertension, arteriosclerosis and aging play important roles.

Entities:  

Mesh:

Year:  1987        PMID: 3665204

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  21 in total

1.  Long-term follow up of renal function in IgA nephropathy.

Authors:  U B Berg
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

2.  Renal histological changes in relation to renal function and urinary protein excretion in IgA nephropathy.

Authors:  U B Berg; S O Bohman; U Widstam-Attorps
Journal:  Arch Dis Child       Date:  1991-05       Impact factor: 3.791

Review 3.  Recognition and management of IgA nephropathy.

Authors:  L S Ibels; A Z Gyory; R J Caterson; C A Pollock; J F Mahony; D A Waugh; S Coulshed
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

4.  Long-term outcome 19 years after childhood IgA nephritis: a retrospective cohort study.

Authors:  Jaana Ronkainen; Marja Ala-Houhala; Helena Autio-Harmainen; Timo Jahnukainen; Olli Koskimies; Jussi Merenmies; Jukka Mustonen; Timo Ormälä; Juha Turtinen; Matti Nuutinen
Journal:  Pediatr Nephrol       Date:  2006-07-13       Impact factor: 3.714

Review 5.  Pathogenesis of glomerular haematuria.

Authors:  Claudia Yuste; Eduardo Gutierrez; Angel Manuel Sevillano; Alfonso Rubio-Navarro; Juan Manuel Amaro-Villalobos; Alberto Ortiz; Jesus Egido; Manuel Praga; Juan Antonio Moreno
Journal:  World J Nephrol       Date:  2015-05-06

6.  A histopathological study on the prognosis of childhood IgA nephropathy and glomerular basement membrane lesions.

Authors:  Y Nomura; N Ohya; M Shimada
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

7.  Use of mizoribine as a rescue drug for steroid-resistant pediatric IgA nephropathy.

Authors:  Yohei Ikezumi; Toshiaki Suzuki; Tamaki Karasawa; Hiroshi Kawachi; David J Nikolic-Paterson; Makoto Uchiyama
Journal:  Pediatr Nephrol       Date:  2007-11-24       Impact factor: 3.714

8.  Prognostication in children with renal disease--with emphasis on IgA nephropathy.

Authors:  R J Hogg; R Browne
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

9.  Follow-up of renal function and urinary protein excretion in childhood IgA nephropathy.

Authors:  U B Berg; U C Widstam-Attorps
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

Review 10.  Idiopathic immunoglobulin A nephropathy in children and adolescents.

Authors:  Ronald J Hogg
Journal:  Pediatr Nephrol       Date:  2009-02-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.